The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 349:2364 December 11, 2003 Number 24
NextNext

Molecular Epidemiology of Tuberculosis

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Barnes, P. F.
-PubMed Citation
To the Editor: In their excellent review of the molecular epidemiology of tuberculosis, Barnes and Cave (Sept. 18 issue)1 recommend that the Centers for Disease Control and Prevention (CDC) support newer, more rapid genotyping tests. In fact, the CDC is doing just that. This winter, two genotyping laboratories will use two polymerase-chain-reaction–based methods — mycobacterial-interspersed-repetitive-units (MIRU) analysis2 and spoligotyping3 — for primary genotyping of Mycobacterium tuberculosis isolates. The laboratories will have the capacity to analyze isolates from every patient with culture-positive tuberculosis in the United States and will report results in less than two weeks. In combination, these methods are . . . [Full Text of this Article]


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.